The GBC Insider index has been publicly listed since September
2016. GBC has been analyzing the notifiable directors' dealings
of all companies domiciled in the German-speaking countries.
In the case of an insider purchase, the related company is
included in the index - assuming that it is also convincing in
the further analysis - and an insider sale leads to an exit
from the index. The GBC IFX generally contains between 30
and 100 shares and is adjusted weekly.
Since the launch, the GBC IFX has significantly outperformed the DAX, MDAX, SDAX and the international benchmarks MSCI World as well as the S&P 500.
"Much more attention should be paid to insider transactions because it really pays off. Thanks to our systematic investment approach, we have included top performers early on, such as Biotest, Leoni, and Rational," says Manuel Hölzle, Chief Analyst of GBC AG. "We are therefore very pleased to be able to offer investors this attractive investment opportunity together with our partners GBC Kapital und Dialog Vermögensmanagement."